D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 49 Citations 6,650 87 World Ranking 2859 National Ranking 1355

Overview

What is she best known for?

The fields of study she is best known for:

  • Virus
  • Immune system
  • Antibody

Anna P. Durbin mainly focuses on Virology, Dengue virus, Dengue fever, Immunology and Dengue vaccine. As part of one scientific family, she deals mainly with the area of Virology, narrowing it down to issues related to the Immunogenicity, and often Plasmodium falciparum. In Dengue virus, she works on issues like Epitope, which are connected to Monoclonal antibody, Vero cell, Infectivity, Humoral immunity and Viral entry.

Her Dengue fever research is multidisciplinary, relying on both T cell and Serotype. Her Dengue vaccine research is multidisciplinary, incorporating elements of Viremia and Disease. Her research investigates the connection between Antigen and topics such as Antibody that intersect with issues in Viral life cycle.

Her most cited work include:

  • Prospects for a dengue virus vaccine. (477 citations)
  • Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51 (340 citations)
  • Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. (263 citations)

What are the main themes of her work throughout her whole career to date?

Anna P. Durbin mostly deals with Virology, Dengue virus, Dengue fever, Immunology and Dengue vaccine. Anna P. Durbin studied Virology and Antibody that intersect with Immunity. Her studies in Dengue virus integrate themes in fields like Neutralizing antibody, Viremia, T cell, Epitope and Monoclonal antibody.

Her work deals with themes such as DNA vaccination, Disease, Immunodominance and Environmental health, which intersect with Dengue fever. Her Vaccination, Immunogenicity, Antigen and Plasmodium falciparum study, which is part of a larger body of work in Immunology, is frequently linked to CpG site, bridging the gap between disciplines. Her work carried out in the field of Dengue vaccine brings together such families of science as Clinical trial, Immune system and Intensive care medicine.

She most often published in these fields:

  • Virology (70.54%)
  • Dengue virus (57.14%)
  • Dengue fever (54.46%)

What were the highlights of her more recent work (between 2018-2021)?

  • Dengue virus (57.14%)
  • Virology (70.54%)
  • Dengue vaccine (45.54%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Dengue virus, Virology, Dengue vaccine, Dengue fever and Vaccination. To a larger extent, she studies Immunology with the aim of understanding Dengue virus. Anna P. Durbin usually deals with Virology and limits it to topics linked to Immunodominance and Infectivity.

Her research integrates issues of Internal medicine, Randomized controlled trial, Seroconversion and Immunogenicity in her study of Dengue vaccine. The various areas that she examines in her Dengue fever study include Tetanus, B cell and Environmental health. Her Vaccination study incorporates themes from Virus, Neutralizing antibody, Seroprevalence and Immunity.

Between 2018 and 2021, her most popular works were:

  • Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response (35 citations)
  • What is the prospect of a safe and effective dengue vaccine for travellers (20 citations)
  • Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. (19 citations)

In her most recent research, the most cited papers focused on:

  • Virus
  • Immune system
  • Antibody

Anna P. Durbin focuses on Dengue vaccine, Dengue fever, Vaccination, Epitope and Dengue virus. Her Dengue vaccine research integrates issues from Clinical trial, Intention-to-treat analysis, Seroconversion and Intensive care medicine. Her Dengue fever research incorporates themes from Seroprevalence, Tetanus and Environmental health.

Her Vaccination study necessitates a more in-depth grasp of Virology. Her Epitope research also covers Antibody and Immunology studies. She regularly ties together related areas like Viral envelope in her Dengue virus studies.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prospects for a dengue virus vaccine.

Stephen S. Whitehead;Joseph E. Blaney;Anna P. Durbin;Brian R. Murphy.
Nature Reviews Microbiology (2007)

755 Citations

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Yimin Wu;Ruth D. Ellis;Donna Shaffer;Erica Fontes.
PLOS ONE (2008)

412 Citations

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn.
American Journal of Tropical Medicine and Hygiene (2001)

382 Citations

Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria

Elissa M. Malkin;David J. Diemert;Julie H. McArthur;John R. Perreault.
Infection and Immunity (2005)

288 Citations

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

Elissa M. Malkin;Anna P. Durbin;David J. Diemert;Jetsumon Sattabongkot.
Vaccine (2005)

261 Citations

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

Anna P. Durbin;Maria José Vargas;Kimberli Wanionek;Samantha N. Hammond.
Virology (2008)

241 Citations

Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

Steevenson Nelson;Christiane A. Jost;Qinq Xu;Jessica Ess.
PLOS Pathogens (2008)

211 Citations

rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers

Anna P. Durbin;Stephen S. Whitehead;Julie McArthur;John R. Perreault.
The Journal of Infectious Diseases (2005)

174 Citations

A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

Anna P. Durbin;Beth D. Kirkpatrick;Kristen K. Pierce;Daniel Elwood.
The Journal of Infectious Diseases (2013)

174 Citations

A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.

Kimberly A. Dowd;Christiane A. Jost;Anna P. Durbin;Stephen S. Whitehead.
PLOS Pathogens (2011)

172 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Anna P. Durbin

Carole A. Long

Carole A. Long

National Institutes of Health

Publications: 97

Kazutoyo Miura

Kazutoyo Miura

National Institutes of Health

Publications: 79

Eva Harris

Eva Harris

University of California, Berkeley

Publications: 71

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 65

Michael S. Diamond

Michael S. Diamond

Washington University in St. Louis

Publications: 59

Aravinda M. de Silva

Aravinda M. de Silva

University of North Carolina at Chapel Hill

Publications: 58

Theodore C. Pierson

Theodore C. Pierson

National Institutes of Health

Publications: 50

Louis H. Miller

Louis H. Miller

National Institutes of Health

Publications: 47

Stephen S. Whitehead

Stephen S. Whitehead

National Institutes of Health

Publications: 45

David L. Narum

David L. Narum

National Institutes of Health

Publications: 43

Pei-Yong Shi

Pei-Yong Shi

The University of Texas Medical Branch at Galveston

Publications: 41

Simon J. Draper

Simon J. Draper

University of Oxford

Publications: 38

Annelies Wilder-Smith

Annelies Wilder-Smith

University of Bern

Publications: 34

Juthathip Mongkolsapaya

Juthathip Mongkolsapaya

Mahidol University

Publications: 33

Patrick E. Duffy

Patrick E. Duffy

National Institutes of Health

Publications: 33

Brian R. Murphy

Brian R. Murphy

National Institutes of Health

Publications: 32

Trending Scientists

Robert M. King

Robert M. King

Smithsonian Institution

Xianhui Bu

Xianhui Bu

California State University, Long Beach

James A. McCloskey

James A. McCloskey

University of Utah

Colin E. Snape

Colin E. Snape

University of Nottingham

Sevilla D. Detera-Wadleigh

Sevilla D. Detera-Wadleigh

National Institutes of Health

Heinz Breer

Heinz Breer

University of Hohenheim

Robert C. Kern

Robert C. Kern

Northwestern University

Jeffrey T. Freymueller

Jeffrey T. Freymueller

Michigan State University

Natalia Restrepo-Coupe

Natalia Restrepo-Coupe

University of Arizona

Christopher F. Dowd

Christopher F. Dowd

University of California, San Francisco

Susan Z. Yanovski

Susan Z. Yanovski

National Institutes of Health

L. Kevin Hamberger

L. Kevin Hamberger

Medical College of Wisconsin

Rogers Brubaker

Rogers Brubaker

University of California, Los Angeles

Jochen Weller

Jochen Weller

Max Planck Society

Juha Äystö

Juha Äystö

University of Jyväskylä

Alexander Akindinov

Alexander Akindinov

Kurchatov Institute

Something went wrong. Please try again later.